Systematic review of risk factors for metastasis to para-aortic lymph nodes in gastric cancer

Surgical Oncology

Volumn 22, Issue 4, 2013, Pages 210-216

  Junfeng, Zhou ^a   Yingxue, Hao ^a   Peiwu, Yu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

D2 plus; Gastric cancer; Metastasis; Para aortic lymph nodes; Para aortic lymphadenectomy; Risk factors

Indexed keywords

CANCER CLASSIFICATION; CANCER INFILTRATION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; DISEASE ASSOCIATION; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; PARAAORTIC LYMPH NODE; PARAAORTIC LYMPH NODE METASTASIS; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TUMOR DIFFERENTIATION;

D2 PLUS; GASTRIC CANCER; METASTASIS; PARA-AORTIC LYMPH NODES; PARA-AORTIC LYMPHADENECTOMY; RISK FACTORS;

HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84889664298     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2013.10.003     Document Type: Review

References (35)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J cancer J Int du Cancer 127 2010 2893 2917
2. M. Sasako, P. McCulloch, T. Kinoshita, and K. Maruyama New method to evaluate the therapeutic value of lymph node dissection for gastric cancer Br J Surg 82 1995 346 351
3. C.W. Wu, C.A. Hsiung, S.S. Lo, M.C. Hsieh, J.H. Chen, and A.F.Y. Li Nodal dissection for patients with gastric cancer: a randomised controlled trial Lancet Oncol 7 2006 309 315
4. M. Sasako, T. Sano, S. Yamamoto, Y. Kurokawa, A. Nashimoto, and A. Kurita D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer N Engl J Med 359 2008 453 462
5. F. Roviello, C. Pedrazzani, D. Marrelli, A. Di Leo, S. Caruso, and S. Giacopuzzi Super-extended (D3) lymphadenectomy in advanced gastric cancer Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 36 2010 439 446
6. Y. Yonemura, C.C. Wu, N. Fukushima, I. Honda, E. Bandou, and T. Kawamura Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy Hepatogastroenterology 54 2007 634 638
7. Y. Fujiwara, S. Takiguchi, K. Nakajima, H. Miyata, M. Yamazaki, and T. Nishida Clinical trials of neo-adjuvant chemotherapy for advanced gastric cancer with peritoneal dissemination Gan To Kagaku Ryoho Cancer Chemother 35 2008 1996 1998
8. J.L. Dikken, J.W. van Sandick, H.A. Maurits Swellengrebel, P.A. Lind, H. Putter, and E.P. Jansen Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS) BMC Cancer 11 2011 329
9. F. De Vita, F. Giuliani, G. Galizia, C. Belli, G. Aurilio, and G. Santabarbara Neo-adjuvant and adjuvant chemotherapy of gastric cancer Ann Oncol Off J Eur Soc Med Oncol/ESMO 18 Suppl. 6 2007 vi120 vi123
10. K. Oyama, S. Fushida, J. Kinoshita, I. Makino, K. Nakamura, and H. Hayashi Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes J Surg Oncol 105 2012 535 541
11. S. Fushida, T. Fujimura, K. Oyama, Y. Yagi, J. Kinoshita, and T. Ohta Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases Anti-cancer Drugs 20 2009 752 756
12. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, DJ. Reynolds, and DJ. Gavaghan Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
13. Japanese Gastric Cancer Association Japanese classification of gastric carcinoma - 2nd English edition Gastric Cancer 1 1998 10 24
14. L.H. Sobin, and Ch Wittekind TNM classification of malignant tumours 6th ed. 2002 Wiley-Liss New York
15. C. Kunisaki, H. Shimada, H. Yamaoka, J. Wakasugi, M. Takahashi, and H. Akiyama Significance of para-aortic lymph node dissection in advanced gastric cancer Hepatogastroenterology 46 1999 2635 2642
16. E. Nomura, M. Sasako, S. Yamamoto, T. Sano, T. Tsujinaka, and T. Kinoshita Risk factors for para-aortic lymph node metastasis of gastric cancer from a randomized controlled trial of JCOG9501 Jpn J Clin Oncol 37 2007 429 433
17. G. De Manzoni, A. Di Leo, G. Borzellino, M. Bonfiglio, C. Pedrazzani, and S. Tasselli Para-aortic lymph node involvement in gastric cancer Ann Chir 126 2001 302 307
18. G. de Manzoni, A. Di Leo, F. Roviello, D. Marrelli, S. Giacopuzzi, and A.M. Minicozzi Tumor site and perigastric nodal status are the most important predictors of para-aortic nodal involvement in advanced gastric cancer Ann Surg Oncol 18 2011 2273 2280
19. H. Liang, L. Wang, Xiaona Wang, Fangxuan Li, Xuewei Dingand, and Jingyu Deng Risk factors for metastasis to para-aortic lymph nodes in gastric cancer: a single institution study in China J Surg Res 173 2013 54 59
20. T. Kosaka, K. Usami, N. Ueshige, T. Hasegawa, S. Yoshitani, and J. Sugaya Paraaortic lymph node dissection for gastric cancer in 244 consecutive cases Hepatogastroenterology 53 2006 629 633
21. Di Wu, Hao Zhang, Caigang Liu, and Ping Lu Result of risk factors for paraaortic lymph node metastasis of gastric cancer based hospital population of two decades Study Prev Cure Tumor(China) 37 11 2010 1273 1276
22. Hui Wu, Xinhua Zhang, Jianbo Xu, Yurong He, Shirong Cai, and Jinping Ma Influencing factors and prognostic impact of para-aortic lymph nodes metastasis in advanced gastric cancer J Dig Oncol(China) 4 2012 82 88
23. Wenhua Zhan, Fanghai Han, Yurong He, Yuming Li, Junsheng Peng, and Shirong Cai Disciplinarian of lymph node metastasis and effect of paraaortic lymph nodes dissection on clinical outcomes in advanced gastric carcinoma Chin J Gastrointest Surg(China) 9 2006 17 22
24. Cancer. JRSfG. Japanese classification of gastric carcinoma 1995 Kanehara Tokyo 10 24
25. L.H. Sobin, and Ch Wittekind International union against cancer TNM classification of malignant tumors 5th ed. 1997 John Wiley New York 59 62
26. Japanese Gastric Cancer Association Japanese classification of gastric carcinoma: 3rd English edition Gastric Cancer 14 2011 101 112
27. J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions version 5.0.1 [updated September 2008] 2008 The Cochrane Collaboration
28. P. McCulloch, M.E. Nita, H. Kazi, and J. Gama-Rodrigues Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach Cochrane Database Syst Rev 2004 CD001964
29. S.H. Yang, Y.C. Zhang, K.H. Yang, Y.P. Li, X.D. He, and J.H. Tian An evidence-based medicine review of lymphadenectomy extent for gastric cancer Am J Surg 197 2009 246 251
30. S. Ohno, S. Tomisaki, H. Oiwa, Y. Sakaguchi, Y. Ichiyoshi, and Y. Maehara Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach J Am Coll Surg 180 1995 577 582
31. M.E. Craanen, W. Dekker, P. Blok, J. Ferwerda, and G.N. Tytgat Time trends in gastric carcinoma: changing patterns of type and location Am J Gastroenterol 87 1992 572 579
32. W.J. Blot, S.S. Devesa, R.W. Kneller, and J.F. Fraumeni Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia J Am Med Assoc 265 1991 1287 1289
33. C. Kunisaki, H. Shimada, M. Nomura, G. Matsuda, Y. Otsuka, and H. Ono Surgical outcome in patients with gastric adenocarcinoma in the upper third of the stomach Surgery 137 2005 165 171
34. S. Takashima, and T. Kosaka Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancer Surg Today 35 2005 425 431
35. C. Matuschek, E. Bolke, M. Peiper, W.T. Knoefel, W. Budach, and A. Erhardt The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract Eur J Med Res 16 2011 265 274